The studies detailed in this application will examine the role of the granule thiol protease, dipeptidyl peptidase I (DPPI) in generation of cytotoxic T lymphocyte (CTL) effector functions and the evolution of in vivo alloimmune responses. DPPI has been found to be expressed at high levels in the specialized effector granules of CTL, natural killer cells, mast cells, and myeloid cells where the enzyme is responsible for post-translational processing and activation of the granule serine proteases expressed in these immune effector cells. Recent studies indicate the presence of specific inhibitors of DPPI during primary alloantigen stimulated T-cell responses not only prevents generation of the enzymatically active forms of the granzyme family of granule serine proteases expressed by CTL but also impairs CD8 (+) T-cell growth and differentiation of multiple cytotoxic effector functions. The proposed studies will examine the mechanisms whereby inhibition of DPPI or other DPPI-like protease(s) impair generation of not only granzyme dependent effector cell function but also appears to modulate other CD8 (+) T-cell responses not previously attributed to granzyme activity.
These specific aims will be addressed: 1) Determine whether DPPI activity or other DPPI-like thiol protease activities play roles in CD8 (+) T-cell growth and differentiation by: (a) assessment of the effects of DPPI-specific antisense oligonucleotides on CD8(+) T-cell growth and proliferation; and (b) characterization of DPPI-like thiol proteases that may play a role in CD8(+) T-cell growth and differentiation; (2) Test the hypothesis that impaired granzyme activation leads to diminished CD8(+) T-cell growth and differentiation by: (a) assessment of the potential toxicity of unprocessed granzyme proteins within DPPI inhibited CTLL-2 and CD8 (+) T-cells; (b) investigation of the role of DPPI-processed granzymes in regulating CD8(+) T-cell growth and differentiation; and (c) assessment of the effects of granzymes on cytokine responses by APC during MLC; (3) Generate DPPI deficient T-cells by targeted disruption of the murine DPPI gene; and (4) Assess the role of DPPI in generation of in vivo cytotoxic effector functions and alloimmune responses during graft versus host disease and organ allograft rejection. These studies should provide new insights into the regulation of CTL effector mechanisms and the role that such effector mechanisms play in complications of bone marrow and organ transplantation.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Immunobiology Study Section (IMB)
Program Officer
Mccarthy, Susan A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Kam, Chih-Min; Gotz, Marion G; Koot, Gretchen et al. (2004) Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C). Arch Biochem Biophys 427:123-34
Brown, Geri R; Lee, Edward L; Thiele, Dwain L (2003) TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. J Immunol 170:5082-8
Brown, Geri R; Lee, Ed; Thiele, Dwain L (2002) TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice. J Immunol 168:3065-71
Brown, G R; Thiele, D L (2000) T-cell activation and differentiation are regulated by TNF during murine DBA/2-->B6D2F1 intestinal graft-versus-host disease. J Clin Immunol 20:379-88
Mabee, C L; Thiele, D L (2000) Mechanisms of autoimmune liver disease. Clin Liver Dis 4:431-45, vii
Brown, G R; Thiele, D L (2000) Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions. Eur J Immunol 30:2900-7
Brown, G R; Lindberg, G; Meddings, J et al. (1999) Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116:593-601
Mabee, C L; McGuire, M J; Thiele, D L (1998) Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation. J Immunol 160:5880-5
Thiele, D L; Lipsky, P E (1992) Spectrum of toxicities of amino acid methyl esters for myeloid cells is determined by distinct metabolic pathways. Blood 79:964-71